Protein A Chromatography Aggregate Removal via pH Gradient Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional protein purification methods, particularly those using Protein A chromatography, face challenges in effectively removing protein aggregates from biopharmaceutical preparations containing Fc-containing proteins, as these aggregates often share similar physical and chemical properties with the target protein, leading to their co-elution and increased impurity in the final product.
Innovation Solution
Employing a Protein A ligand based on the C domain of Protein A and utilizing pH gradient or pH step elution methods to separate at least 30% of protein aggregates before the elution of the Fc-containing protein, thereby increasing the purity of the final product and reducing the need for additional downstream purification steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Protein A chromatography is used to purify Fc-containing proteins, then the target protein is effectively captured and eluted, but protein aggregates co-elute with the target protein resulting in reduced product purity
Solution Approach 1:
The elution process is segmented into multiple distinct phases: a first elution step at lower pH that selectively releases protein aggregates, followed by a second elution step at higher pH that releases the Fc-containing protein. This temporal segmentation of the elution process allows separation of aggregates from the target protein, resolving the contradiction between capture efficiency and product purity.
Solution Approach 2:
The invention utilizes pH as a critical parameter that is dynamically changed during the elution process. By adjusting pH from lower (4.0-5.0) to higher (6.0-8.0) values in sequence, the method selectively controls the binding affinity of Protein A to different protein species, enabling aggregates to be eluted first while maintaining target protein binding, then eluting the target protein in a purified form.
2Manufacturing precision
If additional downstream purification steps are added to remove protein aggregates, then product purity is improved, but process complexity and production time increase
Solution Approach 1:
The invention merges the aggregate removal function with the primary Protein A capture step by implementing a multi-phase elution protocol within the same chromatography column. This integration eliminates the need for separate downstream aggregate removal steps, as the purified eluate from the second elution phase already contains minimal aggregates, thus reducing process complexity while maintaining high purity.
Solution Approach 2:
The Protein A chromatography step is given multi-functionality: it simultaneously performs target protein capture, aggregate separation, and purification in a single operation. The multi-phase elution protocol enables the same column to achieve what would traditionally require multiple separate purification steps, reducing overall process complexity.
3Manufacturing precision
If protein aggregates are removed after elution of Fc-containing protein, then some aggregates are removed, but the majority of aggregates remain in the elution pool reducing overall purity
Solution Approach 1:
The invention performs preliminary removal of protein aggregates during the elution phase itself, before the target protein is released. By conducting the first elution step at lower pH that selectively releases aggregates while the target protein remains bound to the column, the method removes the majority of aggregates in advance. Subsequent elution of the target protein then yields a pre-purified eluate with minimal aggregate content.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described methods achieve a significant reduction in protein aggregates in the elution pool, enhancing the purity of Fc-containing proteins by removing at least 30% of aggregates prior to and after the elution of the target protein, thus simplifying the purification process and improving product quality.
Implementation Method 1
an affinity ligand called Protein A, isolated from Staphylococcus aureus, and which binds the Fc-region of antibodies
Implementation Method 2
use either pH gradient elution or pH step elution, resulting in the elution of at least 30% of the protein aggregates prior to the elution of the Fc-containing protein
Data Source
AI summary
The present invention provides methods for increasing purity of an Fc-containing protein by removing protein aggregates during the Protein A chromatography step used during the purification of the Fc-containing protein.